Literature DB >> 21794095

Centrifugation speed affects light transmission aggregometry.

M Merolla1, M A Nardi, J S Berger.   

Abstract

BACKGROUND: Light transmission aggregometry (LTA) is considered the gold standard for investigating platelet activity ex vivo. However, LTA protocols are not standardized, and differences in LTA procedure are a potential source of variance in results. Centrifugation speed is an essential component of platelet preparation in LTA, has yet to be standardized, and may affect platelet aggregation results. We sought to investigate the effect of relative centrifugal force (RCF) intensity on LTA results.
METHODS: Ten healthy controls had venous blood drawn and centrifuged at 150, 200, 300, and 500 g for 10 min. Cell counts in whole blood and platelet-rich plasma (PRP) were measured using a hematology analyzer. LTA was performed using 1.0 μm adenosine diphosphate (ADP) and 0.4 μm epinephrine as an agonist. Aggregation (%) was compared at 60, 120, 180, and 300 s and at maximum aggregation.
RESULTS: Centrifugation speed was associated with decreasing platelet count (P < 0.001) and decreasing mean platelet volume (P < 0.001) in PRP. Maximum aggregation decreased with increasing speeds for ADP 1.0 μm (150 g- 89%, 200 g- 93%, 300 g- 71%, 500 g- 17%; P < 0.001). Similar findings were noted at 120 s (150 g- 69%, 200 g- 50%, 300 g- 35%, 500 g- 12%; P < 0.001), 180 s (150 g- 82%, 200 g- 74%, 300 g- 44%, 500 g- 13%; P < 0.001), and 300 s (150 g- 85%, 200 g- 88%, 300 g- 55%, 500 g- 14%; P < 0.001). Consistently, platelet aggregation in response to epinephrine 0.4 μm decreased significantly with increasing centrifuge RCF at 60, 120, 180, 300 s and at maximum aggregation (P < 0.05 for each comparison).
CONCLUSION: Our data demonstrate the importance of centrifugation speed in the interpretation of LTA results, supporting the need for standardization of centrifugation RCF in LTA protocols.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21794095      PMCID: PMC3209490          DOI: 10.1111/j.1751-553X.2011.01360.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  12 in total

Review 1.  Can platelet aggregometry be standardized?

Authors:  H K Breddin
Journal:  Platelets       Date:  2005 May-Jun       Impact factor: 3.862

2.  Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count.

Authors:  Marco Cattaneo; Anna Lecchi; Maddalena Loredana Zighetti; Federico Lussana
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

3.  Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH.

Authors:  M Cattaneo; C P M Hayward; K A Moffat; M T Pugliano; Y Liu; A D Michelson
Journal:  J Thromb Haemost       Date:  2009-04-24       Impact factor: 5.824

4.  Methods for platelet aggregation.

Authors:  J J Sixma
Journal:  Adv Exp Med Biol       Date:  1972       Impact factor: 2.622

5.  Guidelines on platelet function testing. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force.

Authors: 
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

6.  Aggregometry detects platelet hyperreactivity in healthy individuals.

Authors:  Donald L Yee; Carol W Sun; Angela L Bergeron; Jing-Fei Dong; Paul F Bray
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

7.  An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts.

Authors:  Catherine P M Hayward; Karen A Moffat; Menaka Pai; Yang Liu; Jodi Seecharan; Heather McKay; Kathryn E Webert; Richard J Cook; Nancy M Heddle
Journal:  Thromb Haemost       Date:  2008-07       Impact factor: 5.249

8.  Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary.

Authors:  B Linnemann; J Schwonberg; H Mani; S Prochnow; E Lindhoff-Last
Journal:  J Thromb Haemost       Date:  2008-01-08       Impact factor: 5.824

Review 9.  Platelet size: measurement, physiology and vascular disease.

Authors:  P M Bath; R J Butterworth
Journal:  Blood Coagul Fibrinolysis       Date:  1996-03       Impact factor: 1.276

10.  Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.

Authors:  Silverio Sbrana; Francesca Della Pina; Antonio Rizza; Manuela Buffa; Rossella De Filippis; Jacopo Gianetti; Aldo Clerico
Journal:  Cytometry B Clin Cytom       Date:  2008-01       Impact factor: 3.058

View more
  9 in total

1.  Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects.

Authors:  Binita Shah; Nicole Allen; Bhisham Harchandani; Michael Pillinger; Stuart Katz; Steven P Sedlis; Christina Echagarruga; Svetlana Krasnokutsky Samuels; Pajazit Morina; Prabhjot Singh; Liza Karotkin; Jeffrey S Berger
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

2.  Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus.

Authors:  Sokha Nhek; Robert Clancy; Kristen A Lee; Nicole M Allen; Tessa J Barrett; Emanuela Marcantoni; Janet Nwaukoni; Sara Rasmussen; Maya Rubin; Jonathan D Newman; Jill P Buyon; Jeffrey S Berger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

3.  Platelet WDR1 suppresses platelet activity and is associated with cardiovascular disease.

Authors:  Emilie Montenont; Christina Echagarruga; Nicole Allen; Elisa Araldi; Yajaira Suarez; Jeffrey S Berger
Journal:  Blood       Date:  2016-09-08       Impact factor: 22.113

4.  High-throughput acoustic separation of platelets from whole blood.

Authors:  Yuchao Chen; Mengxi Wu; Liqiang Ren; Jiayang Liu; Pamela H Whitley; Lin Wang; Tony Jun Huang
Journal:  Lab Chip       Date:  2016-08-01       Impact factor: 6.799

5.  Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study.

Authors:  Meagan O'Brien; Emilie Montenont; Liang Hu; Michael A Nardi; Vanessa Valdes; Michael Merolla; Gabrielle Gettenberg; Karen Cavanagh; Judith A Aberg; Nina Bhardwaj; Jeffrey S Berger
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

6.  Platelet activation increases in patients undergoing vascular surgery.

Authors:  Gabriel S Schneider; Caron B Rockman; Jeffrey S Berger
Journal:  Thromb Res       Date:  2014-08-23       Impact factor: 3.944

7.  Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles.

Authors:  Maria-Argyro Karageorgou; Dimosthenis Stamopoulos
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

8.  The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.

Authors:  Marlien Pieters; Sunelle A Barnard; Du Toit Loots; Dingeman C Rijken
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

9.  Tensile Strength Essay Comparing Three Different Platelet-Rich Fibrin Membranes (L-PRF, A-PRF, and A-PRF+): A Mechanical and Structural In Vitro Evaluation.

Authors:  Mara Simões-Pedro; Pedro Maria B P S Tróia; Nuno Bernardo Malta Dos Santos; António M G Completo; Rogerio Moraes Castilho; Gustavo Vicentis de Oliveira Fernandes
Journal:  Polymers (Basel)       Date:  2022-03-29       Impact factor: 4.329

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.